Study | Animal1 | DOE2 |
Conjugated linoleic acids
|
Feeding practices | ||
---|---|---|---|---|---|---|
Levels (%) | Substituted oils3 | Isomers profiles4 | ||||
Kim et al. (2008) | A | 5×4×10 | 0.5, 1.0, 1.5, 2.0 | No info. | (A), c-9, t-11 (24.1%); t-10, c-12 (25.6%) ; others |
Basal: 1–7 d CLA: 8–35 d |
Aletor et al. (2003) | R | 6×6×9 | 4.0 | Soybean oil (partially) | (B), C18:1 (14.2%); C18:2 (n-6) (4.0%); c-9, t-11 (34.2%); t-10, c-12 (34.0%); other CLA (4.0%); C18:3 (0.02%); other fatty acid (9.6%) |
Basal: 1–21 d CLA: 22–42 d |
Zhang et al. (2008) | A | 4×6×10 | 0.25, 0.5, 1.0 | Soybean oil | (C), c-9, t-11 (39.2%); t10, c12 (38.9%), other CLA (2.0%) | CLA: 1–42 d |
Javadi et al. (2007) | R | 2×8×4 | 1.0 | Sunflower oil | (D), CLA-79.5%; c-9, t-11, t-10, c-12 all in equal amount |
Basal: 1–21 d CLA: 22–28 d |
Ko et al. (2005) | R | 3×2×8 | 0.75, 1.5 | Corn oil | (A), c-9,t-11 (24.1%), t-10, c-12 (25.6%); others |
Basal: 1–21 d CLA: 22–35 d |
Takahashi et al. (2002) | R | 2×8×2 | 1.0 | No info. | (E), c-9, t-11/t-9, c-11 (34.5%); t-10, c-12 (35.7%); c-9, c-12/c-10, c-12, t-9, t-11/t-10, t-12 (2.4%) |
Basal: 1–10 d CLA: 11–24 d |
Aydin (2007) | R | 5×2×35 | 0.5 | Sunflower, olive, beef tallow, hazelnut oils (individually) | (N), c-9, t-11, t-9, c-11 (35.33%); t-10, c-12 (35.72%); c-9, c-11 (1.11%); c-10, c-12 (1.57%); t-9, t-11, t-10, t-12 (0.91%) | CLA: 1–35 d |
Badinga et al. (2003) | R | 2×12×4 | 5.0 | Corn oil | (F), c-9,t-11 (30.7%); t-10,c-12 (30.6%); t-9, t-11 (2.3%) | CLA: 1–21 d |
Shin et al. (2011) | CR | 5×4×6 | 2.0 | Flaxseed and menhaden oils | (G), c-9, c-11 (50%); t-10, c-12 (50%) | CLA: 1–42 d |
4 CLA manufacturers: (A), Chumdan Yangdon Institute, Korea; (B), TrofoCell Research and Trade GmbH, Hamburg, Germany; (C), Auhai Biotech Ltd, Qingdo, P. R. China; (D), Lipid Nutrition B.V. Wormerveer, The Netherland; (E), Rinoru Oil Milss Co. Ltd Tokyo Japan; (F), BASF, D-67056 Ludwigshafen, Germany; (G), Luta-CLA 60, BASF, Ludwigshafen, Germany, (N), no information.
Items1 | df2 | Fixed effect model3 | Random effect model | Heterogeneity | |||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
ES | z-value | p-value | ES | z-value | p-value | N<5%4 | Q5 (p-value) | ||
FBW | 14 | −0.2998 | −4.6391 | <0.0001 | −0.0540 | −0.1630 | 0.8705 | 1 | 361.61 (<0.0001) |
WG | 14 | −0.4939 | −8.2970 | <0.0001 | −0.6410 | −2.7788 | 0.0055 | 1 | 204.53 (<0.0001) |
FI | 11 | −0.3760 | −5.4107 | <0.0001 | −0.4219 | −1.9964 | 0.0492 | 0 | 100.27 (<0.0001) |
FCR | 10 | 0.3737 | 5.3644 | <0.0001 | 0.3867 | 1.9648 | 0.0494 | 0 | 77.61 (<0.0001) |
Items1 | df2 | Fixed effect model3 | Random effect model | Heterogeneity | |||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
ES | z-value | p-value | ES | z-value | p-value | N<5%4 | Q5 (p-value) | ||
TSFA | 7 | 6.0828 | 12.1000 | <0.0001 | 12.1213 | 4.9631 | <0.0001 | 1 | 134.53(<0.0001) |
TUSFA | 10 | −1.6014 | −7.0992 | <0.0001 | −2.9005 | −4.1307 | <0.0001 | 3 | 87.64(<0.0001) |
C16:0 | 8 | 5.3095 | 14.2700 | <0.0001 | 8.1144 | 5.0817 | <0.0001 | 0 | 128.92(<0.0001) |
C18:0 | 8 | 0.5057 | 3.3106 | 0.0009 | 1.8968 | 3.6932 | 0.0002 | 0 | 62.54(<0.0001) |
C18:2 | 11 | −2.0036 | −10.0130 | <0.0001 | −4.2733 | −4.7834 | <0.0001 | 0 | 193.87(<0.0001) |
C18:3 | 10 | 0.5076 | 3.7712 | 0.0002 | 0.3758 | 1.2857 | 0.1985 | 3 | 43.12(<0.0001) |
Category | Items | Slope | Intercept |
---|---|---|---|
Growth performance | FBW | −0.5894±0.2754 (0.0324)1 | 0.8271±0.5186 (0.1107) |
WG | −0.2089±0.2000 (0.2969) | −0.3183±0.3818 (0.4044) | |
FI | −0.2185±0.1952 (0.2632) | −0.0268±0.4152 (0.9485) | |
FCR | −0.0576±0.1813 (0.7507) | 0.4944±0.3981 (0.2143) | |
Fatty acids profiles | Total SFA | −1.2668±2.4261 (0.6000) | 15.0235±5.8924 (0.0108) |
Total USFA | 0.1494±0.6269 (0.8116) | −3.3094±1.735 (0.0562) | |
C16:0 | −0.9898±1.4754 (0.5023) | 10.1301±3.4175 (0.0030) | |
C18:0 | 1.4894±0.5174 (0.0040) | −0.5655±1.0231 (0.5804) | |
C18:3 | −0.2418±0.2810 (0.3894) | 0.8165±0.5983 (0.1724) | |
C18:2 | −0.4063±0.8891 (0.6477) | −3.5627±1.8964 (0.0603) |